Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Healthcare Analytics Market

  • MAR2978612
  • 207 Pages
  • June 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Healthcare Analytics is the collection of data from sources such as clinical data, pharmaceutical and research data, claims and costs data, patient behaviour data for careful analytical analysis which results in improved and efficient healthcare services. TheHealthcare Analytics Market was valued at USAD XXX Billion in 2017 and is expected to reach USAD XXX Billion by 2022, at a CAGR of XX% between 2017 and 2022.

In addition to providing operational advantages to healthcare organisations in terms of revenue management cycleand integration of the health records, it is an effective tool for stratifying population to fulfil public health priorities on epidemiological basis. It can be of great value in national preventive care, empowering patients with rights, health policy recommendation, public health financing, intelligent government expenditure in health infrastructure, and in facilitatingimplementation of healthcare laws for patient safety in developing nations.

Market Dynamics

The major factors driving the growth of Healthcare Analytics market are as under:

1. Increased demand to curb the rising healthcare expenses, better healthcare facilities, improved patient outcomes.

2. Increasing number of patient data coupled with increased usage of data sharing social platforms and blogs will drive the market towards healthcare analytics.

3. Rising awareness about technologies in the field of personalised medicines and improving healthcare infrastructure coupled with incentives and policies in favour of value based and cloud based analytics are also

major drivers of this market.

The major factors which hinder the growth of Healthcare analytics market are as under:

1. The dearth of skilled professionals and IT technicians with sufficient knowledge base and technical expertise.

2. High initial investments and high cost of the analytics solutions coupled with uncertain returns on investment.

3. Data security, breach of confidentiality pertaining to patient's data, dearth of structures for integrating and sharing data.

4. Trouble in establishing a global healthcare network due to fragmented international political and economic relations.

Market Segmentation

The Healthcare Analytics market is bifurcated on the basis of type, delivery mode, application, end user and region. Detailed segmentation is presented as below:

--> On the basis of Type

o Predictive Analysis

o Descriptive Analysis

o Prescriptive Analysis

Out of these descriptive analysis shares and is expected to share the largest share in this segment owing to its use by medical providers to understand the pattern of past records.

--> On the basis of Delivery Model

o On-Demand Model

o On-Premise Model

In this segment the On-Demand model is expected to show the highest growth owing to its pay-as-you-go model, no capital for hardware instalment.

--> On the basis of Application

o Operational and Administrative Analytics

-> Workforce Management

-> Supply Chain Management

-> Strategic Analysis

o Financial Analytics'

-> Claims Processing

-> Fraud, Waste and Abuse (FWA)

-> Risk Adjustment

-> Payment Integrity

-> Revenue Cycle Management (RCM)

o Population Health Analytics

o Clinical Analytics

-> Quality Improvement & Clinical Benchmarking

-> Comparative Analytics/Comparative Effectiveness

-> Clinical Decision Support

-> Precision Health

-> Reporting and Compliance

--> On the basis of End User

o Providers

-> Post-acute Organizations

-> Hospitals, Physician Practices, and IDNs

-> Ambulatory Settings

o Payers

-> Government Agencies

-> Private Insurance Companies

-> Employers & Private Exchanges

--> On the basis of Component

o Services

o Software

o Hardware

--> On the basis of Region

o North America

o Europe

o Asia Pacific

Geographic Analysis

Geographically the market is segmented into following different regions:North America, Europe, Asia Pacific and rest of the world (RoW). North America shares the largest share in the global market and is even expected to be the region showing the highest CAGR in the forecast period. This significant share is attributed to four main factors:

1. The presence of a large of key players base in the region.

2. Openness of the region to adopt advanced technologies coupled with increasing adoption of Electronic Health Records (EHR) across all hospital platforms.

3. Improvement and advancement in healthcare infrastructure further propelled by capital fundings by various players.

4. Government role to reduce increasing medical costs and provide quality healthcare in the form of incentives, legislations like the EHR and other regulations to provide personalised medicines to people.

After this Europe is the next big share holder followed by Asia Pacific. In Asia Pacific, Japan has the largest market share and this is attributed to increasing initiatives b government to reduce the rising costs on medical treatment coupled with increase expenditure on medical needs and use of predictive and prescriptive methods across various hospital platforms.

Key Players

The key players who are driving the market of Healthcare Analytics and determine its future are: IBM Corporation (U.S.A.), Allscripts Health Solutions (U.S.A.), Inovalon (U.S.A.), Oracle Corporation (U.S.A.),Cognizant, Health Catalyst, Med Assets, Inc., McKesson Corporation, SAS Institute Inc.(USA), Truven Health Analytics,Verisk Health(USA), Optum Health(USA), McKesson Corporation(USA), Cerner Corporation(USA), Athena health,Computer Programs and Systems, Change Healthcare, Tenet Healthcare Corporation, GE Healthcare, Evolent Health, Influence Health and Health Catalyst(USA), Mede Analytics, Inc. (U.S.A).

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

1. Market Introduction

1.1. Market Definition

1.2. Market Taxonomy

2. Research Methodology

3. Assumptions and Acronyms

4. Executive Summary

5. Consumer Analysis

5.1. Consumer Profile (Demographic, Geographic, etc.)

5.2. Consumer Motivation

5.3. Procurement Process

5.4. Frequency of Buying

6. Historical Overview (Market Origins, Product Launch Timeline, etc.)

7. Pricing Analysis

8. Market Dynamics

8.1. Macroeconomic Factors

8.2. Drivers

8.2.1. Supply Side

8.2.2. Demand Side

8.3. Restraints

8.4. Opportunities

9. R&D Status and Technology Overview

10. Global Healthcare Analytics Market Analysis, By Data Source

10.1. Introduction

10.2. Prominent Trends

10.3. Regulatory Guidelines

10.4. Market Size and Analysis, By Data Source

10.4.1. Internal Data

10.4.1.1. Patient Data

10.4.1.2. Hospital Data

10.4.1.3. Diagnosis & Treatment Data

10.4.1.4. Medical Imaging Data

10.4.2. External Data

10.4.2.1. Benchmarks Data

10.4.2.2. Public Health Database

10.4.2.3. Government Data

10.4.3. Insurance Data

10.4.4. Pharmacy Data

10.4.5. Social Media Data

10.4.6. Mobile Data

10.5. Market Share Analysis and YoY Growth Rates, By Data Source

11. Global Healthcare Analytics Market Analysis, By Deployment

11.1. Introduction

11.2. Prominent Trends

11.3. Regulatory Guidelines

11.4. Market Size and Analysis, By Deployment

11.4.1. On-Premises

11.4.2. Cloud Based Systems

11.5. Market Share Analysis and YoY Growth Rates, By Deployment

12. Global Healthcare Analytics Market Analysis, By Tools

12.1. Introduction

12.2. Prominent Trends

12.3. Regulatory Guidelines

12.4. Market Size and Analysis, By Tools

12.4.1. Reporting & Dash-boarding Tools

12.4.2. Querying, OLAP and Data Mining Tools

12.4.3. Predictive Modelling Tools

12.4.4. Clinical Health Repositories & Governance

12.4.5. Combination Products

12.5. Market Share Analysis and YoY Growth Rates, By Tools

13. Global Healthcare Analytics Market Analysis, By Consumer

13.1. Introduction

13.2. Prominent Trends

13.3. Regulatory Guidelines

13.4. Market Size and Analysis, By Consumer

13.4.1. Hospitals

13.4.2. Insurance Companies

13.4.3. HMOs

13.4.4. Government Agencies

13.4.5. Pharmacy

13.4.6. Biotechnology

13.4.7. Others

13.5. Market Share Analysis and YoY Growth Rates, By Consumer

14. Global Healthcare Analytics Market Analysis, By Services

14.1. Introduction

14.2. Prominent Trends

14.3. Regulatory Guidelines

14.4. Market Size and Analysis, By Services

14.4.1. Patient Safety Management

14.4.1.1. Clinical Decision Support

14.4.1.2. Anaesthetics Administration

14.4.1.3. Resource Management

14.4.1.4. Emergency Services

14.4.1.5. Others

14.4.2. Clinical Outcomes Management

14.4.2.1. Accountable Care Organisations

14.4.2.2. Others

14.4.3. Wellness & Disease Management

14.4.3.1. Chronic Disease Management

14.4.3.2. Preventive Medicine

14.4.3.3. Population Health Management

14.4.3.4. Others

14.4.4. Hospital Performance Management

14.4.4.1. Feedback Analysis

14.4.4.2. Social Media Analytics

14.4.5. Discovery Analytics [New Gen]

14.4.6. Others

14.5. Market Share Analysis and YoY Growth Rates, By Services

15. Global Healthcare Analytics Market Analysis, By Region

15.1. Introduction

15.2. Prominent Trends

15.3. Regulatory Guidelines

15.4. Market Size and Analysis, By Region

15.4.1. North America

15.4.2. Latin America

15.4.3. Europe

15.4.4. Asia Pacific

15.4.5. Middle East & Africa (MEA)

15.5. Market Share Analysis and YoY Growth Rates, By Region

16. North America Healthcare Analytics Market Analysis

16.1. Introduction

16.2. Prominent Trends

16.3. North America Healthcare Analytics Market Analysis, By Country

16.3.1. U.S.

16.3.2. Canada

16.4. North America Healthcare Analytics Market Size and Analysis, By Data Source

16.4.1. Internal Data

16.4.1.1. Patient Data

16.4.1.2. Hospital Data

16.4.1.3. Diagnosis & Treatment Data

16.4.1.4. Medical Imaging Data

16.4.2. External Data

16.4.2.1. Benchmarks Data

16.4.2.2. Public Health Database

16.4.2.3. Government Data

16.4.3. Insurance Data

16.4.4. Pharmacy Data

16.4.5. Social Media Data

16.4.6. Mobile Data

16.5. North America Healthcare Analytics Market Size and Analysis, By Deployment

16.5.1. On-Premises

16.5.2. Cloud Based Systems

16.6. North America Healthcare Analytics Market Size and Analysis, By Tools

16.6.1. Reporting & Dash-boarding Tools

16.6.2. Querying, OLAP and Data Mining Tools

16.6.3. Predictive Modelling Tools

16.6.4. Clinical Health Repositories & Governance

16.6.5. Combination Products

16.7. North America Healthcare Analytics Market Size and Analysis, By Consumer

16.7.1. Hospitals

16.7.2. Insurance Companies

16.7.3. HMOs

16.7.4. Government Agencies

16.7.5. Pharmacy

16.7.6. Biotechnology

16.7.7. Others

16.8. North America Healthcare Analytics Market Size and Analysis, By Services

16.8.1. Patient Safety Management

16.8.1.1. Clinical Decision Support

16.8.1.2. Anaesthetics Administration

16.8.1.3. Resource Management

16.8.1.4. Emergency Services

16.8.1.5. Others

16.8.2. Clinical Outcomes Management

16.8.2.1. Accountable Care Organisations

16.8.2.2. Others

16.8.3. Wellness & Disease Management

16.8.3.1. Chronic Disease Management

16.8.3.2. Preventive Medicine

16.8.3.3. Population Health Management

16.8.3.4. Others

16.8.4. Hospital Performance Management

16.8.4.1. Feedback Analysis

16.8.4.2. Social Media Analytics

16.8.5. Discovery Analytics [New Gen]

16.8.6. Others

16.9. North America Healthcare Analytics Market Share Analysis and YoY Growth Rates

16.9.1. By Data Source

16.9.2. By Deployment

16.9.3. By Tools

16.9.4. By Consumer

16.9.5. By Services

17. Latin America Healthcare Analytics Market Analysis

17.1. Introduction

17.2. Prominent Trends

17.3. Latin America Healthcare Analytics Market Analysis, By Country

17.3.1. Mexico

17.3.2. Brazil

17.3.3. Others

17.4. Latin America Healthcare Analytics Market Size and Analysis, By Data Source

17.4.1. Internal Data

17.4.1.1. Patient Data

17.4.1.2. Hospital Data

17.4.1.3. Diagnosis & Treatment Data

17.4.1.4. Medical Imaging Data

17.4.2. External Data

17.4.2.1. Benchmarks Data

17.4.2.2. Public Health Database

17.4.2.3. Government Data

17.4.3. Insurance Data

17.4.4. Pharmacy Data

17.4.5. Social Media Data

17.4.6. Mobile Data

17.5. Latin America Healthcare Analytics Market Size and Analysis, By Deployment

17.5.1. On-Premises

17.5.2. Cloud Based Systems

17.6. Latin America Healthcare Analytics Market Size and Analysis, By Tools

17.6.1. Reporting & Dash-boarding Tools

17.6.2. Querying, OLAP and Data Mining Tools

17.6.3. Predictive Modelling Tools

17.6.4. Clinical Health Repositories & Governance

17.6.5. Combination Products

17.7. Latin America Healthcare Analytics Market Size and Analysis, By Consumer

17.7.1. Hospitals

17.7.2. Insurance Companies

17.7.3. HMOs

17.7.4. Government Agencies

17.7.5. Pharmacy

17.7.6. Biotechnology

17.7.7. Others

17.8. Latin America Healthcare Analytics Market Size and Analysis, By Services

17.8.1. Patient Safety Management

17.8.1.1. Clinical Decision Support

17.8.1.2. Anaesthetics Administration

17.8.1.3. Resource Management

17.8.1.4. Emergency Services

17.8.1.5. Others

17.8.2. Clinical Outcomes Management

17.8.2.1. Accountable Care Organisations

17.8.2.2. Others

17.8.3. Wellness & Disease Management

17.8.3.1. Chronic Disease Management

17.8.3.2. Preventive Medicine

17.8.3.3. Population Health Management

17.8.3.4. Others

17.8.4. Hospital Performance Management

17.8.4.1. Feedback Analysis

17.8.4.2. Social Media Analytics

17.8.5. Discovery Analytics [New Gen]

17.8.6. Others

17.9. Latin America Healthcare Analytics Market Share Analysis and YoY Growth Rates

17.9.1. By Data Source

17.9.2. By Deployment

17.9.3. By Tools

17.9.4. By Consumer

17.9.5. By Services

18. Europe Healthcare Analytics Market Analysis

18.1. Introduction

18.2. Prominent Trends

18.3. Europe Healthcare Analytics Market Analysis, By Country

18.3.1. Germany

18.3.2. U.K.

18.3.3. Spain

18.3.4. France

18.3.5. Italy

18.3.6. Russia

18.3.7. Others

18.4. Europe Healthcare Analytics Market Size and Analysis, By Data Source

18.4.1. Internal Data

18.4.1.1. Patient Data

18.4.1.2. Hospital Data

18.4.1.3. Diagnosis & Treatment Data

18.4.1.4. Medical Imaging Data

18.4.2. External Data

18.4.2.1. Benchmarks Data

18.4.2.2. Public Health Database

18.4.2.3. Government Data

18.4.3. Insurance Data

18.4.4. Pharmacy Data

18.4.5. Social Media Data

18.4.6. Mobile Data

18.5. Europe Healthcare Analytics Market Size and Analysis, By Deployment

18.5.1. On-Premises

18.5.2. Cloud Based Systems

18.6. Europe Healthcare Analytics Market Size and Analysis, By Tools

18.6.1. Reporting & Dash-boarding Tools

18.6.2. Querying, OLAP and Data Mining Tools

18.6.3. Predictive Modelling Tools

18.6.4. Clinical Health Repositories & Governance

18.6.5. Combination Products

18.7. Europe Healthcare Analytics Market Size and Analysis, By Consumer

18.7.1. Hospitals

18.7.2. Insurance Companies

18.7.3. HMOs

18.7.4. Government Agencies

18.7.5. Pharmacy

18.7.6. Biotechnology

18.7.7. Others

18.8. Europe Healthcare Analytics Market Size and Analysis, By Services

18.8.1. Patient Safety Management

18.8.1.1. Clinical Decision Support

18.8.1.2. Anaesthetics Administration

18.8.1.3. Resource Management

18.8.1.4. Emergency Services

18.8.1.5. Others

18.8.2. Clinical Outcomes Management

18.8.2.1. Accountable Care Organisations

18.8.2.2. Others

18.8.3. Wellness & Disease Management

18.8.3.1. Chronic Disease Management

18.8.3.2. Preventive Medicine

18.8.3.3. Population Health Management

18.8.3.4. Others

18.8.4. Hospital Performance Management

18.8.4.1. Feedback Analysis

18.8.4.2. Social Media Analytics

18.8.5. Discovery Analytics [New Gen]

18.8.6. Others

18.9. Europe Healthcare Analytics Market Share Analysis and YoY Growth Rates

18.9.1. By Data Source

18.9.2. By Deployment

18.9.3. By Tools

18.9.4. By Consumer

18.9.5. By Services

19. Asia Pacific Healthcare Analytics Market Analysis

19.1. Introduction

19.2. Prominent Trends

19.3. Asia Pacific Healthcare Analytics Market Analysis, By Country

19.3.1. India

19.3.2. China

19.3.3. Australia & New Zealand

19.3.4. Japan

19.3.5. Others

19.4. Asia Pacific Healthcare Analytics Market Size and Analysis, By Data Source

19.4.1. Internal Data

19.4.1.1. Patient Data

19.4.1.2. Hospital Data

19.4.1.3. Diagnosis & Treatment Data

19.4.1.4. Medical Imaging Data

19.4.2. External Data

19.4.2.1. Benchmarks Data

19.4.2.2. Public Health Database

19.4.2.3. Government Data

19.4.3. Insurance Data

19.4.4. Pharmacy Data

19.4.5. Social Media Data

19.4.6. Mobile Data

19.5. Asia Pacific Healthcare Analytics Market Size and Analysis, By Deployment

19.5.1. On-Premises

19.5.2. Cloud Based Systems

19.6. Asia Pacific Healthcare Analytics Market Size and Analysis, By Tools

19.6.1. Reporting & Dash-boarding Tools

19.6.2. Querying, OLAP and Data Mining Tools

19.6.3. Predictive Modelling Tools

19.6.4. Clinical Health Repositories & Governance

19.6.5. Combination Products

19.7. Asia Pacific Healthcare Analytics Market Size and Analysis, By Consumer

19.7.1. Hospitals

19.7.2. Insurance Companies

19.7.3. HMOs

19.7.4. Government Agencies

19.7.5. Pharmacy

19.7.6. Biotechnology

19.7.7. Others

19.8. Asia Pacific Healthcare Analytics Market Size and Analysis, By Services

19.8.1. Patient Safety Management

19.8.1.1. Clinical Decision Support

19.8.1.2. Anaesthetics Administration

19.8.1.3. Resource Management

19.8.1.4. Emergency Services

19.8.1.5. Others

19.8.2. Clinical Outcomes Management

19.8.2.1. Accountable Care Organisations

19.8.2.2. Others

19.8.3. Wellness & Disease Management

19.8.3.1. Chronic Disease Management

19.8.3.2. Preventive Medicine

19.8.3.3. Population Health Management

19.8.3.4. Others

19.8.4. Hospital Performance Management

19.8.4.1. Feedback Analysis

19.8.4.2. Social Media Analytics

19.8.5. Discovery Analytics [New Gen]

19.8.6. Others

19.9. Asia Pacific Healthcare Analytics Market Share Analysis and YoY Growth Rates

19.9.1. By Data Source

19.9.2. By Deployment

19.9.3. By Tools

19.9.4. By Consumer

19.9.5. By Services

20. Middle East and Africa (MEA) Healthcare Analytics Market Analysis

20.1. Introduction

20.2. Prominent Trends

20.3. Middle East and Africa (MEA) Healthcare Analytics Market Analysis, By Country

20.3.1. GCC Countries

20.3.2. South Africa

20.3.3. North Africa

20.3.4. Rest of Middle East and Africa

20.4. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Data Source

20.4.1. Internal Data

20.4.1.1. Patient Data

20.4.1.2. Hospital Data

20.4.1.3. Diagnosis & Treatment Data

20.4.1.4. Medical Imaging Data

20.4.2. External Data

20.4.2.1. Benchmarks Data

20.4.2.2. Public Health Database

20.4.2.3. Government Data

20.4.3. Insurance Data

20.4.4. Pharmacy Data

20.4.5. Social Media Data

20.4.6. Mobile Data

20.5. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Deployment

20.5.1. On-Premises

20.5.2. Cloud Based Systems

20.6. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Tools

20.6.1. Reporting & Dash-boarding Tools

20.6.2. Querying, OLAP and Data Mining Tools

20.6.3. Predictive Modelling Tools

20.6.4. Clinical Health Repositories & Governance

20.6.5. Combination Products

20.7. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Consumer

20.7.1. Hospitals

20.7.2. Insurance Companies

20.7.3. HMOs

20.7.4. Government Agencies

20.7.5. Pharmacy

20.7.6. Biotechnology

20.7.7. Others

20.8. Middle East and Africa (MEA) Healthcare Analytics Market Size and Analysis, By Services

20.8.1. Patient Safety Management

20.8.1.1. Clinical Decision Support

20.8.1.2. Anaesthetics Administration

20.8.1.3. Resource Management

20.8.1.4. Emergency Services

20.8.1.5. Others

20.8.2. Clinical Outcomes Management

20.8.2.1. Accountable Care Organisations

20.8.2.2. Others

20.8.3. Wellness & Disease Management

20.8.3.1. Chronic Disease Management

20.8.3.2. Preventive Medicine

20.8.3.3. Population Health Management

20.8.3.4. Others

20.8.4. Hospital Performance Management

20.8.4.1. Feedback Analysis

20.8.4.2. Social Media Analytics

20.8.5. Discovery Analytics [New Gen]

20.8.6. Others

20.9. Middle East and Africa (MEA) Healthcare Analytics Market Share Analysis and YoY Growth Rates

20.9.1. By Data Source

20.9.2. By Deployment

20.9.3. By Tools

20.9.4. By Consumer

20.9.5. By Services

21. Industry Structure

21.1. Porters Five Forces Analysis

21.1.1. Bargaining Power of Suppliers

21.1.2. Bargaining Power of Buyers

21.1.3. Threat of New Entrants

21.1.4. Threat of Substitute Products and Services

21.1.5. Internal Rivalry

21.2. Supply Chain Analysis and Profitability Margins

21.3. Market Share Analysis

21.4. Strategic Analysis

21.4.1. Competitive Strategies

21.4.2. Mergers & Acquisitions Activity

21.4.3. Co-operative Agreements

21.5. Critical Success Factor (CSF) Analysis (Technology & Manufacturing, Design & Features, Brand Reputation, Distribution Network, Marketing)

21.6. Company Profiles (Overview, Product/Service Details, Geographic Scope, Financials, Strategic Intent & Approach, Core Competencies & Competitive Advantage and Key developments)

21.6.1. IBM

21.6.2. Wipro

21.6.3. Allscripts

21.6.4. Tableau

21.6.5. Cerner Corporation

21.6.6. Health Catalyst

21.6.7. Inovalon

21.6.8. McKesson

21.6.9. MEDEANALYTICS

21.6.10. Optum

21.6.11. Oracle

21.6.12. SAS Institute

21.6.13. SCIOInspire

21.6.14. Verscend Technologies

21.6.15. CitiusTech

21.6.16. Vitreos Health

21.6.17. Ikon Tech IQVIA

21.6.18. GENERAL ELECTRIC

22. Prognosis for the Future

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390